Johnson & Johnson’s recently made public that its EVP, WWC. Innovative Medicine Taubert Jennifer L unloaded Company’s shares for reported $10.04 million on Sep 04 ’25. In the deal valued at $177.81 per share,56,471 shares were sold. As a result of this transaction, Taubert Jennifer L now holds 178,013 shares worth roughly $33.97 million.
Then, Taubert Jennifer L bought 56,471 shares, generating $10,040,904 in total proceeds.
Before that, Forminard Elizabeth bought 9,570 shares. Johnson & Johnson shares valued at $1,695,806 were divested by the Officer at a price of $177.20 per share.
Wells Fargo upgraded its Johnson & Johnson [JNJ] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who increased its forecast for the stock in late September from “a Neutral” to “a Buy”. Erste Group also remained covering JNJ and has increased its forecast on July 23, 2025 with a “Buy” recommendation from previously “Hold” rating. Leerink Partners revised its rating on May 13, 2025. It rated JNJ as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of JNJ
On Tuesday, Johnson & Johnson [NYSE:JNJ] saw its stock fall -0.03% to $190.85. Over the last five days, the stock has gained 1.04%. Johnson & Johnson shares have risen nearly 18.90% since the year began. Nevertheless, the stocks have risen 31.97% over the past one year.
How much short interest is there in Johnson & Johnson?
A steep rise in short interest was recorded in Johnson & Johnson stocks on 2025-09-30, dropping by -0.66 million shares to a total of 18.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 18.84 million shares. There was a decline of -3.62%, which implies that there is a negative sentiment for the stock.
